Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1296 |
---|---|
Product Name | Anti-Human IGF1 & IGF2 Recombinant Antibody(Dusigitumab) |
Molecular Name | Dusigitumab |
Alias | Anti-IGF1 & IGF2 Recombinant Antibody, Research Grade Dusigitumab |
CAS Number | 1204390-13-5 |
Target | IGF1 & IGF2[Homo sapiens] |
Isotype | IgG2 |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, IHC |
Buffer | PBS, pH7.5 |
Background | Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2. It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |